BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19728366)

  • 1. PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.
    Ding YS; Singhal T; Planeta-Wilson B; Gallezot JD; Nabulsi N; Labaree D; Ropchan J; Henry S; Williams W; Carson RE; Neumeister A; Malison RT
    Synapse; 2010 Jan; 64(1):30-8. PubMed ID: 19728366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased norepinephrine transporter availability in obesity: Positron Emission Tomography imaging with (S,S)-[(11)C]O-methylreboxetine.
    Li CS; Potenza MN; Lee DE; Planeta B; Gallezot JD; Labaree D; Henry S; Nabulsi N; Sinha R; Ding YS; Carson RE; Neumeister A
    Neuroimage; 2014 Feb; 86():306-10. PubMed ID: 24121204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of in vivo brain norepinephrine transporter and age, BMI, and gender.
    Koohsari S; Sadabad FE; Pittman B; Gallezot JD; Carson RE; van Dyck CH; Li CR; Potenza MN; Matuskey D
    Synapse; 2023 Sep; 77(5):e22279. PubMed ID: 37382240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress.
    Logan J; Wang GJ; Telang F; Fowler JS; Alexoff D; Zabroski J; Jayne M; Hubbard B; King P; Carter P; Shea C; Xu Y; Muench L; Schlyer D; Learned-Coughlin S; Cosson V; Volkow ND; Ding YS
    Nucl Med Biol; 2007 Aug; 34(6):667-79. PubMed ID: 17707807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging human brown adipose tissue under room temperature conditions with (11)C-MRB, a selective norepinephrine transporter PET ligand.
    Hwang JJ; Yeckel CW; Gallezot JD; Aguiar RB; Ersahin D; Gao H; Kapinos M; Nabulsi N; Huang Y; Cheng D; Carson RE; Sherwin R; Ding YS
    Metabolism; 2015 Jun; 64(6):747-55. PubMed ID: 25798999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emotional eating and in vivo norepinephrine transporter availability in obesity: A [
    Bresch A; Rullmann M; Luthardt J; Becker GA; Reissig G; Patt M; Ding YS; Hilbert A; Sabri O; Hesse S
    Int J Eat Disord; 2017 Feb; 50(2):152-156. PubMed ID: 27611116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Quantification of the Norepinephrine Transporter in Human Brain with (
    Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
    J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant doses of methylphenidate significantly occupy norepinephrine transporters in humans in vivo.
    Hannestad J; Gallezot JD; Planeta-Wilson B; Lin SF; Williams WA; van Dyck CH; Malison RT; Carson RE; Ding YS
    Biol Psychiatry; 2010 Nov; 68(9):854-60. PubMed ID: 20691429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
    Ding YS; Lin KS; Logan J; Benveniste H; Carter P
    J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.
    Takano A; Varrone A; Gulyás B; Karlsson P; Tauscher J; Halldin C
    Neuroimage; 2008 Aug; 42(2):474-82. PubMed ID: 18617423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of norepinephrine transporters.
    Ding YS; Lin KS; Logan J
    Curr Pharm Des; 2006; 12(30):3831-45. PubMed ID: 17073682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of [11C]MRB as a prospective PET ligand for imaging the norepinephrine transporter.
    Severance AJ; Milak MS; Kumar JSD; Prabhakaran J; Majo VJ; Simpson NR; Van Heertum RL; Arango V; Mann JJ; Parsey RV
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):688-693. PubMed ID: 17180600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
    Arakawa R; Okumura M; Ito H; Seki C; Takahashi H; Takano H; Nakao R; Suzuki K; Okubo Y; Halldin C; Suhara T
    J Nucl Med; 2008 Aug; 49(8):1270-6. PubMed ID: 18632811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus.
    Pietrzak RH; Gallezot JD; Ding YS; Henry S; Potenza MN; Southwick SM; Krystal JH; Carson RE; Neumeister A
    JAMA Psychiatry; 2013 Nov; 70(11):1199-1205. PubMed ID: 24048210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs.
    Ding YS; Lin KS; Garza V; Carter P; Alexoff D; Logan J; Shea C; Xu Y; King P
    Synapse; 2003 Dec; 50(4):345-52. PubMed ID: 14556239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [(11)C]MRB for assessment of occupancy of norepinephrine transporters: Studies with atomoxetine in non-human primates.
    Gallezot JD; Weinzimmer D; Nabulsi N; Lin SF; Fowles K; Sandiego C; McCarthy TJ; Maguire RP; Carson RE; Ding YS
    Neuroimage; 2011 May; 56(1):268-79. PubMed ID: 20869448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and analysis of PET studies with norepinephrine transporter ligands: the search for a reference region.
    Logan J; Ding YS; Lin KS; Pareto D; Fowler J; Biegon A
    Nucl Med Biol; 2005 Jul; 32(5):531-42. PubMed ID: 15982584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult attention-deficit/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[
    Ulke C; Rullmann M; Huang J; Luthardt J; Becker GA; Patt M; Meyer PM; Tiepolt S; Hesse S; Sabri O; Strauß M
    Transl Psychiatry; 2019 Nov; 9(1):301. PubMed ID: 31732713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hunger and disinhibition but not cognitive restraint are associated with central norepinephrine transporter availability.
    Bresch A; Rullmann M; Luthardt J; Becker GA; Patt M; Ding YS; Hilbert A; Sabri O; Hesse S
    Appetite; 2017 Oct; 117():270-274. PubMed ID: 28647385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.
    Zeng F; Mun J; Jarkas N; Stehouwer JS; Voll RJ; Tamagnan GD; Howell L; Votaw JR; Kilts CD; Nemeroff CB; Goodman MM
    J Med Chem; 2009 Jan; 52(1):62-73. PubMed ID: 19067522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.